PubMed

Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective.

Scherbaum WA, Goodall G, Erny-Albrecht KM, Massi-Benedetti M, Erdmann E, Valentine WJ.

Cost Eff Resour Alloc. 2009 May 5;7:9.PMID: 19416529 [PubMed - in process]Related articlesFree article

Treatment of type 2 diabetes with combined therapy: what are the pros and cons?

Massi-Benedetti M, Orsini-Federici M.

Diabetes Care. 2008 Feb;31 Suppl 2:S131-5. Review.PMID: 18227473 [PubMed - indexed for MEDLINE]Related articlesFree article

PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study.

Erdmann E, Dormandy J, Wilcox R, Massi-Benedetti M, Charbonnel B.

Vasc Health Risk Manag. 2007;3(4):355-70. Review.PMID: 17969365 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical validation of a new control-oriented model of insulin and glucose dynamics in subjects with type 1 diabetes.

Fabietti PG, Canonico V, Orsini-Federici M, Sarti E, Massi-Benedetti M.

Diabetes Technol Ther. 2007 Aug;9(4):327-38.PMID: 17705688 [PubMed - indexed for MEDLINE]Related articles

Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08).

Erdmann E, Charbonnel B, Wilcox RG, Skene AM, Massi-Benedetti M, Yates J, Tan M, Spanheimer R, Standl E, Dormandy JA; PROactive investigators.

Diabetes Care. 2007 Nov;30(11):2773-8. Epub 2007 Jul 31.PMID: 17666462 [PubMed - indexed for MEDLINE]Related articlesFree article

PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.

Valentine WJ, Bottomley JM, Palmer AJ, Brändle M, Foos V, Williams R, Dormandy JA, Yates J, Tan MH, Massi-Benedetti M; PROactive Study Group.

Diabet Med. 2007 Sep;24(9):982-1002. Epub 2007 Jun 25.PMID: 17593245 [PubMed - indexed for MEDLINE]Related articles

Quality and behavior of glimepiride generics versus amaryl under stressed conditions.

Attorrese G, Massi-Benedetti M.

Diabetes Technol Ther. 2007 Jun;9(3):287-96. Erratum in: Diabetes Technol Ther. 2007 Oct;9(5):482. PMID: 17561799 [PubMed - indexed for MEDLINE]Related articles

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.

Erdmann E, Dormandy JA, Charbonnel B, Massi-Benedetti M, Moules IK, Skene AM; PROactive Investigators.

J Am Coll Cardiol. 2007 May 1;49(17):1772-80. Epub 2007 Apr 16.PMID: 17466227 [PubMed - indexed for MEDLINE]Related articles

Changing targets in the treatment of type 2 diabetes.

Massi-Benedetti M.

Curr Med Res Opin. 2006;22 Suppl 2:S5-13. Review.PMID: 16914071 [PubMed - indexed for MEDLINE]Related articles

Model based study on monitoring ketone bodies to improve safety in intensive insulin therapy.

Fabietti PG, Canonico V, Orsini Federici M, Sarti E, Massi Benedetti M.

Int J Artif Organs. 2006 Jun;29(6):596-601.PMID: 16841289 [PubMed - indexed for MEDLINE]Related articles

National survey on the execution of the oral glucose tolerance test (OGTT) in a representative cohort of Italian laboratories.

Federici MO, Mosca A, Testa R, Lapolla A, Andreani P, Massi Benedetti M; Italian Society of Clinical Biochemistry and Clinical Molecular Biology; Italian Society of Laboratory Medicine.

Clin Chem Lab Med. 2006;44(5):568-73.PMID: 16681426 [PubMed - indexed for MEDLINE]Related articles

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J; PROactive investigators.

Lancet. 2005 Oct 8;366(9493):1279-89.PMID: 16214598 [PubMed - indexed for MEDLINE]Related articles

The costs of type 2 diabetes mellitus in Italy: a CODE-2 sub-study.

Lucioni C, Garancini MP, Massi-Benedetti M, Mazzi S, Serra G; CODE-2 Italian Advisory Board.

Treat Endocrinol. 2003;2(2):121-33.PMID: 15871548 [PubMed - indexed for MEDLINE]Related articles

Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.

Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A.

Diabetes Care. 2005 Apr;28(4):950-5.PMID: 15793205 [PubMed - indexed for MEDLINE]Related articlesFree article

Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes.

Hovorka R, Canonico V, Chassin LJ, Haueter U, Massi-Benedetti M, Orsini Federici M, Pieber TR, Schaller HC, Schaupp L, Vering T, Wilinska ME.

Physiol Meas. 2004 Aug;25(4):905-20.PMID: 15382830 [PubMed - indexed for MEDLINE]Related articles

The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients.

Charbonnel B, Dormandy J, Erdmann E, Massi-Benedetti M, Skene A; PROactive Study Group.

Diabetes Care. 2004 Jul;27(7):1647-53.PMID: 15220241 [PubMed - indexed for MEDLINE]Related articlesFree article

Closing the loop: the adicol experience.

Hovorka R, Chassin LJ, Wilinska ME, Canonico V, Akwi JA, Federici MO, Massi-Benedetti M, Hutzli I, Zaugg C, Kaufmann H, Both M, Vering T, Schaller HC, Schaupp L, Bodenlenz M, Pieber TR.

Diabetes Technol Ther. 2004 Jun;6(3):307-18.PMID: 15198833 [PubMed - indexed for MEDLINE]Related articles

Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience.

Massi-Benedetti M.

Clin Ther. 2003 Mar;25(3):799-816. Review.PMID: 12852703 [PubMed - indexed for MEDLINE]Related articles

The artificial pancreas.

Brunetti P, Orsini Federici M, Massi Benedetti M.

Artif Cells Blood Substit Immobil Biotechnol. 2003 May;31(2):127-38. Review.PMID: 12751831 [PubMed - indexed for MEDLINE]Related articles

A one-year, randomised, multicentre trial comparing insulin glargine with NPH insulin in combination with oral agents in patients with type 2 diabetes.

Massi Benedetti M, Humburg E, Dressler A, Ziemen M.

Horm Metab Res. 2003 Mar;35(3):189-96.PMID: 12734781 [PubMed - indexed for MEDLINE]Related articles

The cost of diabetes Type II in Europe: the CODE-2 Study.

Massi-Benedetti M; CODE-2 Advisory Board.

Diabetologia. 2002 Jul;45(7):S1-4. Epub 2002 May 24. No abstract available. PMID: 12136404 [PubMed - indexed for MEDLINE]Related articles

PROMODR: Progressive Model for Diabetes Register.

Massi Benedetti M, Orsini Federici M.

Diabetes Nutr Metab. 2001 Apr;14(2):96-100. Review. No abstract available. PMID: 11383682 [PubMed - indexed for MEDLINE]Related articles

A review of European experience with aggregated diabetes databases in the delivery of quality care to establish a future vision of their structure and role.

Vaughan NJ, Massi Benedetti M.

Diabetes Nutr Metab. 2001 Apr;14(2):86-7. No abstract available. PMID: 11383678 [PubMed - indexed for MEDLINE]Related articles

The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes. The QuED Study Group--quality of care and outcomes in type 2 diabetes.

Belfiglio M, De Berardis G, Franciosi M, Cavaliere D, Di Nardo B, Greenfield S, Kaplan SH, Pellegrini F, Sacco M, Tognoni G, Valentini M, Nicolucci A, Caimi V, Capani F, Corsi A, Della Vedova R, Massi Benedetti M, Nicolucci A, Taboga C, Tombesi M, Vespasiani G; QuED Study Group--quality of care and outcomes in type 2 diabetes.

Diabetes Care. 2001 Mar;24(3):423-9.PMID: 11289462 [PubMed - indexed for MEDLINE]Related articlesFree article

Postprandial glucose: the nondiabetic state.

Massi-Benedetti M, Orsini-Federici M.

Diabetes Obes Metab. 2000 Mar;2 Suppl 1:S1-6. Review. No abstract available. PMID: 11225754 [PubMed - indexed for MEDLINE]Related articles

Pharmacology and clinical experience with repaglinide.

Massi-Benedetti M, Damsbo P.

Expert Opin Investig Drugs. 2000 Apr;9(4):885-98. Review.PMID: 11060717 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular risk factors in type 2 diabetes: the role of hyperglycaemia.

Massi-Benedetti M, Federici MO.

Exp Clin Endocrinol Diabetes. 1999;107 Suppl 4:S120-3. Review.PMID: 10522835 [PubMed - indexed for MEDLINE]Related articles

Patterns of care an Italian diabetic population. The Italian Study Group for the Implementation of the St Vincent Declaration, Società Italiana di Diabetologia, Associazione Medici Diabetologi.

Nicolucci A, Scorpiglione N, Belfiglio M, Carinci F, Cavaliere D, el-Shazly M, Labbrozzi D, Mari E, Massi Benedetti M, Tognoni G.

Diabet Med. 1997 Feb;14(2):158-66.PMID: 9047095 [PubMed - indexed for MEDLINE]Related articles

Epidemiology and determinants of blood glucose self-monitoring in clinical practice.

Scorpiglione N, el-Shazly M, Abdel-Fattah M, Belfiglio M, Cavaliere D, Carinci F, Labbrozzi D, Mari E, Massi Benedetti M, Tognoni G, Nicolucci A.

Diabetes Res Clin Pract. 1996 Oct;34(2):115-25.PMID: 9031814 [PubMed - indexed for MEDLINE]Related articles

The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide.

Massi-Benedetti M, Herz M, Pfeiffer C.

Horm Metab Res. 1996 Sep;28(9):451-5.PMID: 8911982 [PubMed - indexed for MEDLINE]Related articles

A chip card for patients with diabetes.

Engelbrecht R, Hildebrand C, Kühnel E, Brenner G, Corcoy R, Eberhard G, Gapp C, Klepser G, de Leiva A, Massi-Benedetti M, et al.

Comput Methods Programs Biomed. 1994 Oct;45(1-2):33-5.PMID: 7889759 [PubMed - indexed for MEDLINE]Related articles

Time delay compensation for closed-loop insulin delivery systems: a simulation study.

Reboldi GP, Home PD, Calabrese G, Fabietti PG, Brunetti P, Massi Benedetti M.

Int J Artif Organs. 1991 Jun;14(6):350-8.PMID: 1885243 [PubMed - indexed for MEDLINE]Related articles

Closed-loop delivery systems for insulin therapy.

Brunetti P, Massi Benedetti M, Calabrese G, Reboldi GP.

Int J Artif Organs. 1991 Apr;14(4):216-26. No abstract available. PMID: 2060988 [PubMed - indexed for MEDLINE]Related articles

Wearable system for acquisition, processing and storage of the signal from amperometric glucose sensors.

Fabietti PG, Massi Benedetti M, Bronzo F, Reboldi GP, Sarti E, Brunetti P.

Int J Artif Organs. 1991 Mar;14(3):175-8.PMID: 2045193 [PubMed - indexed for MEDLINE]Related articles

Hormonal and metabolic responses in brittle diabetic patients during feedback intravenous insulin infusion.

Massi Benedetti M, Home PD, Gill GV, Burrin JM, Noy GA, Alberti KG.

Diabetes Res Clin Pract. 1987 Nov-Dec;3(6):307-17.PMID: 3311678 [PubMed - indexed for MEDLINE]Related articles

[Glycometabolic effects of treatment with low-dose metformin]

Gregorio F, Filipponi P, Angelici F, Carloni C, Cristallini S, Pietropaolo M, Calafiore R, Massi-Benedetti M.

Recenti Prog Med. 1986 Dec;77(12):549-53. Italian. No abstract available. PMID: 3563081 [PubMed - indexed for MEDLINE]Related articles

An L-lactate sensor with immobilized enzyme for use in in vivo studies with an endocrine artificial pancreas.

Mascini M, Fortunati S, Moscone D, Palleschi G, Massi-Benedetti M, Fabietti P.

Clin Chem. 1985 Mar;31(3):451-3.PMID: 3971566 [PubMed - indexed for MEDLINE]Related articlesFree article

The response of blood intermediary metabolite levels to 24 hours treatment with a blood glucose-controlled insulin infusion system in type 1 diabetes.

Capaldo B, Home PD, Massi-Benedetti M, Worth R, Cook DB, Heaton A, Alberti KG.

Diabetes Res. 1984 Nov;1(4):187-93.PMID: 6397293 [PubMed - indexed for MEDLINE]Related articles

[Hormono-metabolic profiles of patients with diabetes mellitus type 2 and acquired sulfonylurea insensitivity]

Scionti L, Calafiore R, Calcinaro F, Massi-Benedetti M, Santeusanio F, Brunetti P.

Minerva Endocrinol. 1984 Apr-Jun;9(2):253-6. Italian. No abstract available. PMID: 6503909 [PubMed - indexed for MEDLINE]Related articles

[Conventional insulin therapy]

Brunetti P, Santeusanio F, Calabrese G, Massi-Benedetti M, Bolli G.

Minerva Endocrinol. 1984 Apr-Jun;9(2):69-77. Review. Italian. No abstract available. PMID: 6390145 [PubMed - indexed for MEDLINE]Related articles

Metabolic effects of intensified insulin therapy.

Brunetti P, Bueti A, Antonella MA, Calabrese G, Fabietti PG, Santeusanio F, Massi Benedetti M.

Exp Clin Endocrinol. 1984 Apr;83(2):130-5.PMID: 6373314 [PubMed - indexed for MEDLINE]Related articles

Kinetics and metabolic activity of biosynthetic NPH insulin evaluated by the glucose clamp technique.

Massi Benedetti M, Bueti A, Mannino D, Bellomo G, Antonella MA, Calabrese G, Zega G, Brunetti P.

Diabetes Care. 1984 Mar-Apr;7(2):132-6.PMID: 6376009 [PubMed - indexed for MEDLINE]Related articles

Comparison of the activity and pharmacokinetics of porcine insulin and human insulin (Novo) as assessed by the glucose clamp technique in normal and diabetic man.

Home PD, Shepherd GA, Noy G, Massi-Benedetti M, Hanning I, Burrin JM, Alberti KG.

Diabetes Care. 1983 Mar-Apr;6 Suppl 1:23-8.PMID: 6343033 [PubMed - indexed for MEDLINE]Related articles

Hormonal and metabolic profiles in insulin-dependent diabetics under subcutaneous conventional and artificial endocrine pancreas (glucose continuous insulin infusion system Biostator) treatment.

Calabrese G, Bueti A, Santeusanio F, Giombolini A, Zega G, Bellomo G, Antonella MA, Angeletti G, Massi-Benedetti M, Brunetti P.

J Endocrinol Invest. 1983 Feb;6(1):1-8. No abstract available. PMID: 6341441 [PubMed - indexed for MEDLINE]Related articles

[Use of the endocrine artificial pancreas (GCIIS; Biostator) in heart surgery]

Calabrese G, Bueti A, Zega G, Bellomo G, Antonella MA, Giombolini A, Tardioli F, Massi-Benedetti M, Palminiello A.

Minerva Med. 1982 Dec 22;73(49-50):3509-14. Italian. PMID: 7155400 [PubMed - indexed for MEDLINE]Related articles

Impaired subcutaneous absorption of insulin in 'brittle' diabetics.

Home PD, Massi-Benedetti M, Gill GV, Capaldo B, Shepherd GA, Alberti KG.

Acta Endocrinol (Copenh). 1982 Nov;101(3):414-20.PMID: 6756010 [PubMed - indexed for MEDLINE]Related articles

Improvement of artificial endocrine pancreas (Biostator; GCIIS) performance combining feedback controlled insulin administration with a pre-programmed insulin infusion.

Calabrese G, Bueti A, Zega G, Giombolini A, Bellomo G, Antonella MA, Massi-Benedetti M, Brunetti P.

Horm Metab Res. 1982 Oct;14(10):505-7.PMID: 6757081 [PubMed - indexed for MEDLINE]Related articles

Circulating catecholamine and glucagon responses to insulin-induced blood glucose decrement in a patient with pheochromocytoma.

Bolli G, De Feo P, Massi-Benedetti M, Compagnucci P, Cartechini MG, Santeusanio F, Brunetti P.

J Clin Endocrinol Metab. 1982 Feb;54(2):447-9.PMID: 7033279 [PubMed - indexed for MEDLINE]Related articles

A comparison of the activity and disposal of semi-synthetic human insulin and porcine insulin in normal man by the glucose clamp technique.

Home PD, Massi-Benedetti M, Shepherd GA, Hanning I, Alberti KG, Owens DR.

Diabetologia. 1982 Jan;22(1):41-5.PMID: 7037507 [PubMed - indexed for MEDLINE]Related articles

Clinical trial with porcine des-Phe B1 insulin. A comparative study with unmodified insulin on therapeutical efficacy, biological activity and immunogenicity.

Santeusanio F, Massi-Benedetti M, Clementi A, Calabrese G, Bueti A, Picchio E, Brunetti P.

Diabete Metab. 1981 Sep;7(3):173-9.PMID: 7033008 [PubMed - indexed for MEDLINE]Related articles